These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 232017)

  • 21. Effects of angiotensin I converting enzyme inhibitor (SQ 14225) on control of aldosterone.
    Eguchi T; Saito I; Nakamura R; Yasui T; Saruta T
    Acta Endocrinol (Copenh); 1980 Jun; 94(2):213-20. PubMed ID: 6251687
    [No Abstract]   [Full Text] [Related]  

  • 22. Converting enzyme inhibition with captopril in patients with primary hyperaldosteronism.
    Luderer JR; Demers LM; Harrison TS; Hayes AH
    Clin Pharmacol Ther; 1982 Mar; 31(3):305-11. PubMed ID: 6277545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of captopril and hydrochlorothiazide on the response to pressor agents in hypertensives.
    Fruncillo RJ; Rotmensch HH; Vlasses PH; Koplin JR; Swanson BN; Ferguson RK
    Eur J Clin Pharmacol; 1985; 28(1):5-9. PubMed ID: 3886401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Captopril, an orally active converting enzyme inhibitor, in the treatment of primary hypertension. A controlled long-term study with reference to initial plasma renin activity.
    Karlberg BE; Asplund J; Nilsson OR; Wettre S; Ohman KP
    Acta Med Scand; 1981; 209(4):245-52. PubMed ID: 7015795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute changes in blood pressure and vasoactive hormones after captopril in hypertensive patients.
    McGrath BP; Matthews PG; Johnston CI
    Clin Exp Pharmacol Physiol; 1980; 7(5):487-91. PubMed ID: 7004680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyponatraemic hypertensive syndrome with renal-artery occlusion corrected by captopril.
    Atkinson AB; Davies DL; Leckie B; Morton JJ; Brown JJ; Fraser R; Lever AF; Robertson JI
    Lancet; 1979 Sep; 2(8143):606-9. PubMed ID: 90271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of captopril on renal hemodynamics in hypertensive patients.
    Duchin KL; Willard DA
    J Clin Pharmacol; 1984; 24(8-9):351-9. PubMed ID: 6384279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure.
    Atkinson AB; Cumming AM; Brown JJ; Fraser R; Leckie B; Lever AF; Morton JJ; Robertson JI
    Br J Clin Pharmacol; 1982 Jun; 13(6):855-8. PubMed ID: 7046776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose captopril: its use in mild to moderate hypertension unresponsive to diuretic treatment.
    Vlasses PH; Rotmensch HH; Swanson BN; Mojaverian P; Ferguson RK
    Arch Intern Med; 1982 Jun; 142(6):1098-101. PubMed ID: 6284081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme.
    Weber MA; Drayer JI; Priest RT; Chen TC
    Am J Nephrol; 1982; 2(1):6-11. PubMed ID: 6295161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of sympathetic nervous system activity in the blood pressure response to long-term captopril therapy in severely hypertensive patients.
    Weinberger MH
    Am J Cardiol; 1982 Apr; 49(6):1542-3. PubMed ID: 7041594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for the role of kinins in the acute antihypertensive effect of captopril in low-renin hypertension.
    Mizuno K; Haruyama K; Gotoh M; Matsui J; Fukuchi S
    Jpn Heart J; 1984 May; 25(3):379-86. PubMed ID: 6381785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response of arterial blood pressure, plasma renin activity and plasma aldosterone concentration to long-term administration of captopril in patients with severe, treatment-resistant malignant hypertension.
    McCaa CS; Langford HG; Cushman WC; McCaa RE
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():371s-373s. PubMed ID: 396084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [An experimental study on the effects of the chronic administration of an angiotensin converting enzyme inhibitor (captopril) on blood pressure and the renin-angiotensin-aldosterone system (author's transl)].
    Goto A
    Nihon Naibunpi Gakkai Zasshi; 1980 Jun; 56(6):868-83. PubMed ID: 6997093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocrine profile in the long-term phase of converting-enzyme inhibition.
    Swartz SL; Williams GH; Hollenberg NK; Crantz FR; Moore TJ; Levine L; Sasahara AA; Dluhy RG
    Clin Pharmacol Ther; 1980 Oct; 28(4):499-508. PubMed ID: 6250761
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effects of angiotensin converting enzyme inhibitor SQ 14,225 on the blood pressure, renin-angiotensin-aldosterone system and renal function in patients with malignant hypertension (author's transl)].
    Shionoiri H; Uneda S; Tochikubo O; Ohonishi T; Harada J; Sesoko S; Goto E; Fujishima S; Kaneko Y
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):13-22. PubMed ID: 6247528
    [No Abstract]   [Full Text] [Related]  

  • 37. Effective use of captopril (angiotensin I-converting enzyme inhibitor) in severe childhood hypertension.
    Friedman A; Chesney RW; Ball D; Goodfriend T
    J Pediatr; 1980 Oct; 97(4):664-7. PubMed ID: 6999143
    [No Abstract]   [Full Text] [Related]  

  • 38. Hormonal and metabolic effects of angiotensin converting enzyme inhibitors. Possible differences between enalapril and captopril.
    Atlas SA; Case DB; Yu ZY; Laragh JH
    Am J Med; 1984 Aug; 77(2A):13-7. PubMed ID: 6089554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of combined therapy with amiloride and hydrochlorothiazide on plasma and total body potassium, blood pressure, and the renin-angiotensin-aldosterone system in hypertensive patients.
    Svendsen UG; Ibsen H; Rasmussen S; Leth A; Nielsen MD; Dige-Petersen H; Giese J
    Eur J Clin Pharmacol; 1986; 30(2):151-6. PubMed ID: 3519243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical improvement and hormonal changes in severe cardiac failure after captopril treatment.
    McGrath BP; Denham IM; Johnston CI
    Aust N Z J Med; 1981 Dec; 11(6):639-44. PubMed ID: 6277291
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.